woman with cancer laying in hospital bed

NICE recommend new endometrial cancer treatment within the Cancer Drug Fund

NICE have recommended a new cancer treatment for people with advanced or recurrent endometrial cancer. The new treatment has been recommended for use in adults who have had platinum-based chemotherapy.

The immunotherapy, also known as dostarlimab, could benefit 124 people a year across England as a second-line treatment for endometrial cancer (EC).

A dostarlimab infusion takes up to 30 minutes opposed to a round of chemotherapy which can take up to a day to administer.

Helen Knight, programme director in the Centre for Health Technology Evaluation at NICE, said: “We are committed to helping to provide early access for patients to promising new treatments, such as dostarlimab, which is available from today.

“Our committee concluded that people with previously treated advanced or recurrent endometrial cancer need new options and the overall evidence suggests that this treatment is more effective than current care so could offer a considerable improvement in quality of life.

“This is a significant development because dostarlimab provides, for the first time, a targeted immunotherapy treatment for people with the mismatch repair deficiency biomarker. Previously there were no targeted treatments licensed for this condition.

“While dostarlimab cannot be recommended for routine use in the NHS at this stage it is being recommended for use in the Cancer Drugs Fund so that more comparative data and long-term evidence can be collected to address clinical uncertainties.”

The most common type of EC is endometrioid carcinoma, which results in an estimated 2,162 deaths each year in the UK.

Currently, there are various treatments available for EC after having platinum-based chemotherapy but there are no standard second-line treatments, resulting in poor patient prognosis dur to limited survival benefit.

A price discount has been provided to the NHS, however had been kept confidential.

NHE March/April 22

NHE Jan/Feb 22

Calling time on stop gap solutions

The new edition of NHE’s e-magazine highlights the newest digital innovation, environmental efforts, procurement projects and more with articles from the likes of Lord Victor Adebowale, Chair of the NHS Confederation (pg38), Health Education England and NHS Supply Chain.  


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all